Literature DB >> 11768290

A stochastic model describes the heterogeneous pharmacokinetics of cyclosporin.

L Claret1, A Iliadis, P Macheras.   

Abstract

The pharmacokinetics of cyclosporin (CsA) are unusual because of several heterogeneous features which include the presence of more than one conformer, considerable accumulation in erythrocytes and lipoproteins, extensive plasma protein binding, distribution into deep tissues, biliary secretion and hepatic clearance involving a large number of metabolites. In this study, a stochastic compartmental model was developed to describe the heterogeneous elimination kinetics of CsA. This new approach relies on a probabilistic transfer model with a gamma distributed probability intensity coefficient for drug elimination. For comparative purposes both the stochastic model and compartmental deterministic models were fitted to real post infusion data from patients receiving CsA as a 2-hr intravenous infusion. The criteria for selecting the best model showed that the stochastic model, although simpler than the compartmental deterministic models, is more flexible and gives a better fit to the kinetic data of CsA than the compartmental deterministic models. The stochastic model with a random rate intensity coefficient adequately describes the heterogeneous pharmacokinetics of CsA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11768290     DOI: 10.1023/a:1012295014352

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  22 in total

Review 1.  Overview of new immunosuppressive therapies.

Authors:  T E Nevins
Journal:  Curr Opin Pediatr       Date:  2000-04       Impact factor: 2.856

2.  A general approach to non-Markovian compartmental models.

Authors:  J H Matis; T E Wehrly
Journal:  J Pharmacokinet Biopharm       Date:  1998-08

3.  Some generalized stochastic compartment models for digesta flow.

Authors:  J H Matis; T E Wehrly; W C Ellis
Journal:  Biometrics       Date:  1989-09       Impact factor: 2.571

4.  Use of cyclosporine by constant-rate intravenous infusion immediately after heart transplantation.

Authors:  S A Myre; T J Schroeder; D B Melvin; C W Clardy; A J Pesce; N K Wadhwa; J A Collins; R K Wolf; L L Brown; G W Stephens
Journal:  Transplant Proc       Date:  1988-06       Impact factor: 1.066

5.  [Blood pharmacokinetic parameters of cyclosporin A and nephrotoxicity. Diagnostic and predictive value in renal transplantation].

Authors:  F Serre-Debeauvais; S Benzekri; J L Alix; P Vialtel; M Gavend
Journal:  Therapie       Date:  1988 Jan-Feb       Impact factor: 2.070

6.  Michaelis-Menten kinetics determine cyclosporine steady-state concentrations: a population analysis in kidney transplant patients.

Authors:  J Grevel; B K Post; B D Kahan
Journal:  Clin Pharmacol Ther       Date:  1993-06       Impact factor: 6.875

7.  On some stochastic formulations and related statistical moments of pharmacokinetic models.

Authors:  J H Matis; T E Wehrly; C M Metzler
Journal:  J Pharmacokinet Biopharm       Date:  1983-02

8.  A fractal approach to heterogeneous drug distribution: calcium pharmacokinetics.

Authors:  P Macheras
Journal:  Pharm Res       Date:  1996-05       Impact factor: 4.200

9.  Prediction of blood cyclosporine concentrations in haematological patients with multidrug resistance by one-, two- and three-compartment models using Bayesian and non-linear least squares methods.

Authors:  G Wu; P Cossettini; M Furlanut
Journal:  Pharmacol Res       Date:  1996 Jul-Aug       Impact factor: 7.658

10.  Physiologic modeling of cyclosporin kinetics in rat and man.

Authors:  A Bernareggi; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1991-02
View more
  5 in total

1.  Multivariate statistics of disposition pharmacokinetic parameters for structurally unrelated drugs used in therapeutics.

Authors:  Vangelis Karalis; Anna Tsantili-Kakoulidou; Panos Macheras
Journal:  Pharm Res       Date:  2002-12       Impact factor: 4.200

Review 2.  Advanced pharmacokinetic models based on organ clearance, circulatory, and fractal concepts.

Authors:  K Sandy Pang; Michael Weiss; Panos Macheras
Journal:  AAPS J       Date:  2007-06-29       Impact factor: 4.009

3.  How to avoid unbounded drug accumulation with fractional pharmacokinetics.

Authors:  Maud Hennion; Emmanuel Hanert
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-12       Impact factor: 2.745

4.  A series acceleration algorithm for the gamma-Pareto (type I) convolution and related functions of interest for pharmacokinetics.

Authors:  Carl A Wesolowski; Jane Alcorn; Geoffrey T Tucker
Journal:  J Pharmacokinet Pharmacodyn       Date:  2021-10-24       Impact factor: 2.745

5.  Comparison of the gamma-Pareto convolution with conventional methods of characterising metformin pharmacokinetics in dogs.

Authors:  Carl A Wesolowski; Surajith N Wanasundara; Paul S Babyn; Jane Alcorn
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-12-21       Impact factor: 2.745

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.